W6782723006

• Predicting multifaceted risks using machine learning in atrial fibrillation: insights from GLORIA-AF study

  2024 European Heart Journal - Digital Health article Medicine Atrial Fibrillation Management and Outcomes Open access

  13

  citations
• Dyspnea in patients with atrial fibrillation: Mechanisms, assessment and an interdisciplinary and integrated care approach

  2022 IJC Heart & Vasculature article Medicine Atrial Fibrillation Management and Outcomes Open access

  20

  citations
• COMPARE LAAO: Rationale and design of the randomized controlled trial “COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at high stroke risk and ineligible to use oral anticoagulation therapy”

  2022 American Heart Journal article Medicine Atrial Fibrillation Management and Outcomes Open access

  17

  citations
• Switching from vitamin K antagonists to direct oral anticoagulants in non‐valvular atrial fibrillation patients: Does low time in therapeutic range affect persistence?

  2021 Journal of Thrombosis and Haemostasis article Medicine Atrial Fibrillation Management and Outcomes Open access

  13

  citations
• Low bleeding and thromboembolic risk with continued dabigatran during cardiovascular interventions: the GLORIA-AF study

  2021 European Journal of Internal Medicine article Medicine Atrial Fibrillation Management and Outcomes

  4

  citations
• Pulmonary vein isolation in a real-world population does not influence QTc interval

  2020 EP Europace article Medicine Atrial Fibrillation Management and Outcomes Open access

  8

  citations
• Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry

  2020 Hellenic Journal of Cardiology article Medicine Atrial Fibrillation Management and Outcomes Open access

  3

  citations

7 results